News

Ovarian Cancer Research Fund and National Sponsor QVC Expan...

Ovarian Cancer Research Fund and National Sponsor QVC Expand Woman to Woman

March 10, 2014

Program Gynecologic Cancer Patients to Receive New Support in Providence, New Orleans, Houston and The Bronx WEST CHESTER, Pa (March 10, 2014) —Ovarian Cancer Research Fund (OCRF) and QVC today announced four new Woman to Woman grant recipients: Women & Infants Hospital of Rhode Island, Providence, RI; Tulane Cancer Center, New Orleans, LA; Baylor College … Continued

OCRA News

Early oophorectomy cuts risk of death in BRCA mutation carr...

Early oophorectomy cuts risk of death in BRCA mutation carriers

February 28, 2014

New research published this week suggests that women with BRCA1 mutations should have a prophylactic oophorectomy by the age of 35 to lessen their risk of developing and dying from ovarian cancer. By contrast, the  study recommended that surgical intervention could be delayed until the 40s for BRCA2 mutation carriers. You can read the full … Continued

Research

Study Shows BRCA1 Mutation Carriers Should Remove Ovaries b...

Study Shows BRCA1 Mutation Carriers Should Remove Ovaries by Age 35

February 25, 2014

The findings of a large international study published in the Journal of Clinical Oncology suggest for the first time that women with BRCA1 mutations should have preventive ovarian surgery (prophylactic oophorectomy) by age 35. The report studied nearly 5,800 women with specific genetic mutations called BRCA1 and BRCA2. Researchers found that women with BRCA1 and … Continued

Research

High-dose Vitamin C Helps Ovarian Cancer Patients

High-dose Vitamin C Helps Ovarian Cancer Patients

February 21, 2014

(February 21, 2014) Scientists at the University of Kansas Medical Center have determined that high doses of vitamin C, administered intravenously with traditional chemotherapy, helped kill cancer cells while reducing the toxic effects of chemotherapy for some cancer patients. By evaluating the therapy in cells, animals, and humans, the researchers found that a combination of … Continued

Research

High-dose Vitamin C may boost chemotherapy effectiveness

High-dose Vitamin C may boost chemotherapy effectiveness

February 11, 2014

High-doses of vitamin C delivered in conjunction with IV chemotherapy may boost chemotherapy’s effectiveness and reduce side-effects in ovarian cancer treatment, according to a new study published this week. Researchers from the University of Kansas Medical Center found that patients who received vitamin C in conjunction with the conventional chemotherapy drugs paclitaxel or carboplatin reported … Continued

Research

Regular Aspirin Use May Reduce Ovarian Cancer Risk

Regular Aspirin Use May Reduce Ovarian Cancer Risk

February 10, 2014

(February 10, 2014) Women who take aspirin daily may reduce their risk of ovarian cancer by 20 percent, according to a study by scientists at the National Cancer Institute (NCI).  However, further research is needed before clinical recommendations can be made. The study, which was conducted as part of the OCRF-funded Ovarian Cancer Association Consortium, … Continued

Research

Press Release: Ovarian Cancer Advocates Applaud Findings on...

Press Release: Ovarian Cancer Advocates Applaud Findings on Aspirin and Risk Reduction

February 7, 2014

FOR IMMEDIATE RELEASE: February 7, 2014 Further Study Needed Before Clinical Recommendations Change Washington, DC—A study published yesterday by the National Institutes of Health found that women who took aspirin on a daily basis had a 20 percent reduction in risk of ovarian cancer. The Ovarian Cancer National Alliance released the following statement in response … Continued

OCRA News

Study Shows 1 in 5 Women with Ovarian Cancer has Inherited ...

Study Shows 1 in 5 Women with Ovarian Cancer has Inherited Predisposition

January 31, 2014

(January 31, 2014)  A new study conservatively estimates that one in five women with ovarian cancer has inherited genetic mutations that increase the risk of the disease, according to research at Washington University School of Medicine in St. Louis. Most women in the study would have been unaware of a genetic predisposition to ovarian cancer because … Continued

Research

OCRF Research Finds New Factor in Ovarian Cancer Development

OCRF Research Finds New Factor in Ovarian Cancer Development

January 30, 2014

  (January 30, 2014)  OCRF grantee Yin Wang, PhD, led research which found that PKC iota signaling plays an important role in ovarian cancer development. The research, which was published in Molecular Cancer Research, also found that Auranofin,  a small molecular compound, shows potential for treating ovarian cancer. The research study was funded in part by … Continued

OCRA News

Partner Member Profile: Ovarian Cancer Alliance of Arizona

Partner Member Profile: Ovarian Cancer Alliance of Arizona

January 28, 2014

In 2008, a group of ovarian cancer patients and survivors created the Ovarian Cancer Alliance of Arizona. They were tired of the lack of resources in Arizona: no support network, no one to talk to outside of the doctor’s office, no extracurricular meetings or events, and no resources for caretakers. They started OCAZ to fill … Continued

Community

1 in 5 women with ovarian cancer have a genetic predisposition

1 in 5 women with ovarian cancer have a genetic predisposition

January 28, 2014

At least 20% of women with ovarian cancer have a genetic predisposition to the disease even if they don’t have a family history ovarian cancer, according to a recent study. Researchers at Washington University School of Medicine in St. Louis analyzed the genes in ovarian cancer tumor samples from over 400 women with no family … Continued

Research

Press Release: Cancer Advocates Debunk Huckabee’s Misleadin...

Press Release: Cancer Advocates Debunk Huckabee’s Misleading Comments on Oral Contraceptives

January 24, 2014

FOR IMMEDIATE RELEASE: January 24, 2014 Washington, DC—In response to a recent speech by Mike Huckabee, in which he stated that women use oral contraceptives because they “cannot control their libidos or their reproductive systems,” the Ovarian Cancer National Alliance issued the following statement from CEO Calaneet Balas: “In his quest for a quotable sound … Continued

Advocacy